The biopharmaceutical company reported ($0.43) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.32). The stock exchanged hands 1.6 Million shares versus average trading capacity of 1.51 Million shares.
Dynavax Technologies Corporation (DVAX) belonging to the Healthcare sector has surged 1.02% and closed its last trading session at $19.85.
Shares of NASDAQ DVAX traded down $0.50 during trading on Tuesday, reaching $18.30. Dynavax Technologies Corporation (NASDAQ:DVAX) has risen 231.67% since April 2, 2017 and is uptrending.
Strategic Global Advisors Llc decreased its stake in Brunswick Corp (BC) by 11.58% based on its latest 2017Q4 regulatory filing with the SEC. Short-term as well long term shareholders always focus on the liquidity of the stocks so for that concern, liquidity measure in recent quarter results of the company was recorded 10.70 as current ratio and on the opponent side the debt to equity ratio was 0.00 and long-term debt to equity ratio also remained 0.00. A statistical measure of the dispersion of returns (volatility) for DVAX producing salvation in Investors mouth, it has week volatility of 6.89% and for the month booked as 5.80%. It has underperformed by 4.18% the S&P500. Out of 4 Wall Street analysts rating Dynavax, 2 give it "Buy", 0 "Sell" rating, while 2 recommend "Hold". Therefore 67% are positive. Cowen and Company reissued an "outperform" rating and issued a $45.00 target price on shares of Dynavax Technologies Corp.in a research report on Tuesday, September 6th. Dynavax Technologies Corporation (DVAX) has shown a upward trend during time of recent session. The rating was maintained by William Blair on Friday, July 21 with "Buy". One equities research analyst has rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating to the company's stock. The rating was downgraded by J.P. Morgan to "Hold" on Wednesday, February 14. About 1.61 million shares traded or 6.01% up from the average. The company was maintained on Tuesday, March 27 by RBC Capital Markets. The rating was maintained by Cantor Fitzgerald with "Buy" on Thursday, November 9.
Investors sentiment decreased to 1 in 2017 Q4. Its down 1.06, from 2.06 in 2017Q3.
In other Dynavax Technologies news, insider David F. Novack sold 16,109 shares of the stock in a transaction that occurred on Thursday, March 15th. 113 funds opened positions while 282 raised stakes.
Large investors have recently bought and sold shares of the business. Following the transaction, the vice president now directly owns 7,780 shares in the company, valued at approximately $144,708.
The PEG ratio is used to determine a stock's value while taking the company's earnings growth into account, and is considered to provide a more complete picture than the P/E. Dynavax Technologies (NASDAQ:DVAX) has a current PEG of 0. Meeder Asset Mngmt invested 0% of its portfolio in Dynavax Technologies Corporation (NASDAQ:DVAX). Citadel Advsrs Limited Liability Corp accumulated 225,299 shares. "(DVAX) Will Announce Earnings of -$0.51 Per Share" was first posted by StockNewsTimes and is the property of of StockNewsTimes. Rhumbline Advisers invested in 0% or 62,656 shares.
Dynavax Technologies Corporation (NASDAQ: DVAX) has obvious gauge of stock volatility. Metropolitan Life Ins Co Ny accumulated 19,450 shares. Martingale Asset Limited Partnership holds 0.01% or 4,515 shares in its portfolio.
A number of other hedge funds have also modified their holdings of DVAX. Goldman Sachs Grp invested in 167,234 shares.
Since December 13, 2017, it had 0 insider purchases, and 5 sales for $1.07 million activity. Another trade for 7,500 shares valued at $141,750 was sold by COFFMAN ROBERT. Shares for $57,511 were sold by Johnson David Louis. 3,100 shares were sold by Dekker Christopher F, worth $182,394. Voya Investment Management LLC increased its holdings in shares of Dynavax Technologies by 26.3% in the second quarter. Finally, Vanguard Group Inc. boosted its position in shares of Dynavax Technologies by 10.9% during the 2nd quarter. For the next year, analysts anticipate that the firm will report earnings of ($1.03) per share, with EPS estimates ranging from ($1.45) to ($0.54). Automatic Data had 58 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was maintained by Jefferies with "Hold" on Thursday, February 1. A value between 0 to -20 would represent a strong overbought condition. The rating was upgraded by Forward View Consulting on Sunday, September 3 to "Buy". The firm earned "Buy" rating on Monday, January 22 by RBC Capital Markets. Northcoast maintained Brunswick Corporation (NYSE:BC) rating on Monday, January 29. The company presently has a consensus rating of "Buy" and a consensus price target of $24.67. BidaskClub lowered shares of Dynavax Technologies from a "buy" rating to a "hold" rating in a research report on Wednesday, December 6th.